DALLAS, July 31, 2017 /PRNewswire/ — Ideal Implant Incorporated announced today that Paul Herchman, Co-Founder and former CEO of ThermiGen, LLC was appointed to its Board of Directors, and will act as a consultant in Corporate Development for Ideal Implant. The company also announced that current Board member Kevin Morano will assume the role of Chief Financial Officer, continuing to lead the company’s financial strategy, and National Sales Director Gabe Walters has been promoted to Vice President of U.S. Sales. “Ideal Implant has grown significantly over the last year and with that growth, we need to be continually adding talent and expertise that can take the company to…
Author: Press Release
ATLANTA – Deanna Roberts has pleaded guilty to four felony counts of possessing, transporting, and ultimately illegally injecting persons with liquid silicone and four felony counts of introducing into interstate commerce liquid silicone, which was an adulterated device. One of the women the defendant injected with liquid silicone died about 36 hours after receiving the injection when the silicone migrated to her lungs, heart, brain, and other organs. “Roberts admitted that she caused the death of one person by injecting her with liquid silicone, and that she also injected liquid silicone into multiple other people, putting their lives at considerable risk,” said…
BOSTON, Oct. 16, 2015 /PRNewswire/ — Ideal Implant Incorporated announced that the five-year clinical study results for the IDEAL IMPLANT® Structured Breast Implant will be presented at the Hot Topics in Plastic Surgery symposium during the annual meeting of the American Society of Plastic Surgeons (ASPS). Presentation: Breast Implant Update–New Technology in Breast ProsthesesDate: October 16, 2015Time: 11 a.m.- 4 p.m.Location: Boston Convention and Exhibition Center; Boston, MA The clinical trial results will be presented by Larry S. Nichter, MD, Voluntary Clinical Professor of Plastic Surgery at University of Southern California and University of California, Irvine and Immediate Past Chairman of the Department of Plastic Surgery at Hoag Memorial Hospital in Newport Beach, California.…
Dallas, Sept. 16, 2015 / PRNewswire / — Ideal Implant Incorporated announced today that the FDA-approved IDEAL IMPLANT® Structured Breast Implant is now available for use in the United States and Canada. The IDEAL IMPLANT is the first implant to provide women with the natural feel of silicone gel-filled implants combined with the safety of only saline inside. “After years of dealing with ruptured silicone gel implants and listening to patient complaints about the unnatural feel of original saline implants, I realized that women were looking for a new type of breast implant. This led me to develop the IDEAL IMPLANT,” said Robert S…
Silver Spring, MD., June 22, 2011 /PRNewswire-USNewswire/ The U.S. Food and Drug Administration released a report today updating the clinical and scientific information for silicone gel-filled breast implants, including preliminary safety data from studies conducted by the manufacturers as a condition of their November 2006 approval. While the report confirms that silicone gel-filled breast implants are safe and effective when used as intended, women should fully understand the risks prior to considering silicone gel-filled breast implants for breast augmentation or reconstruction. Based on the report, women should know: Breast implants are not lifetime devices. The longer a woman has silicone gel-filled breast implants,…
U.S. FDA, January 26, 2011 For FDA’s most current information on anaplastic large cell lymphoma in women with breast implants, see our Anaplastic Large Cell Lymphoma (ALCL) web page. Date Issued: January 26, 2011 Audience: Health care providers involved in the care of patients with breast implantsHospital tumor boardsBreast implant patients and families of patients, including those that have received breast implants for aesthetic augmentation, revision, or reconstruction.Patients considering breast implant surgery Medical Specialties: Radiology, Pathology, Plastic Surgery, General Surgery, Internal Medicine, Obstetrics/Gynecology, Oncology, Nursing, General Practice Purpose: The FDA is issuing this communication to inform health care providers and…